famotidine and s 1033

famotidine has been researched along with s 1033 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bédoucha, V; Hussaini, A; McCulloch, T; Novick, S; Yin, OQ; Zheng, C; Zhou, W	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1

Reviews

1 review(s) available for famotidine and s 1033

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for famotidine and s 1033

Article	Year
Effects of famotidine or an antacid preparation on the pharmacokinetics of nilotinib in healthy volunteers. Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:1 Topics: Administration, Oral; Adult; Antacids; Antineoplastic Agents; Area Under Curve; Cross-Over Studies; Drug Administration Schedule; Drug Interactions; Famotidine; Female; Humans; Male; Middle Aged; Protein Kinase Inhibitors; Pyrimidines; Therapeutic Equivalency	2013

Article

Year

Effects of famotidine or an antacid preparation on the pharmacokinetics of nilotinib in healthy volunteers.

Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:1

Topics: Administration, Oral; Adult; Antacids; Antineoplastic Agents; Area Under Curve; Cross-Over Studies; Drug Administration Schedule; Drug Interactions; Famotidine; Female; Humans; Male; Middle Aged; Protein Kinase Inhibitors; Pyrimidines; Therapeutic Equivalency

2013